18 evolution-"https:"-"https:"-"https:"-"https:"-"IRIBHM-ULB" positions at Ghent University
Sort by
Refine Your Search
-
Department PS05 - Department of Conflict and Development Studies Degree Masters Diploma Occupancy rate 100% Vacancy type Research staff ABOUT GHENT UNIVERSITY The Conflict Research Group (CRG) , based
-
), is willing to support one or more applications for Doctoral Scholarships for candidates from the Global South through the Ghent University development programme. One mandatory requirement is that you
-
Bekijk Nederlandstalige versie The Industrial Research Fund (IOF) supports the development of application-oriented knowledge and technology and its transfer to business, government and the non
-
review of your proposal. As a successful ERC-grantee A ten-year appointment, potentially to be extended A wide range of career development opportunities Administrative support by the EU team Contact: EU
-
) at Ghent University is seeking a highly motivated PhD candidate to join our research program on the plasma-assisted development of advanced tissue engineering scaffolds. The project explores how cold plasmas
-
? Equipment: The purchase of (components for) the research infrastructure or the upgrade of already existing infrastructure Staff costs: For the development and construction or permanent operation of
-
. Bert Devriendt focuses on gut immunology and host-pathogen interactions at the intestinal surface. Our main interest is in pathogenic E. coli and the development of novel therapies to control
-
particular, combined with a flexible and creative mindset. Affinity with sports is a welcome plus. Strong software development skills. Clear scientific and communicative skills (e.g., critical thinking
-
) at Ghent University is seeking a highly motivated PhD candidate to join our research program on the plasma-assisted development of advanced tissue engineering scaffolds. The project explores how cold plasmas
-
in patients, and 3) the development of innovative strategies for eradicating HIV reservoirs. In addition, we aim to take our innovations to the clinical stage, conducting trials that push the